Alzamend Neuro, Inc. (ALZN)

NASDAQ: ALZN · IEX Real-Time Price · USD
1.04
+0.03 (2.97%)
Aug 12, 2022 1:42 PM EDT - Market open

Ratios and Metrics (Trailing)

Market cap in millions USD. Fiscal year is May - April.
Millions USD. Fiscal year is May - Apr.
Quarter Ending Current2022-04-302022-01-312021-10-312021-07-31
Market Capitalization
9992136186377
Enterprise Value
8578124173362
PE Ratio
--7.43-13.94-22.41-62.39
PB Ratio
7.446.8811.3614.2824.60
Debt / Equity Ratio
-000.030.02
Debt / EBITDA Ratio
-00-0.04-0.06
Debt / FCF Ratio
-00-0.06-0.09
Current Ratio
12.3712.3726.629.8311.41
Return on Equity (ROE)
-92.10%-92.10%-92.10%-114.10%-
Return on Assets (ROA)
-84.90%-84.90%-83.60%-94.70%-
Return on Capital (ROIC)
-7280.30%-8505.10%-31797.60%-
Earnings Yield
-12.45%-13.45%-7.17%-4.46%-1.60%
FCF Yield
-6.77%-7.31%-4.64%-2.87%-0.99%
Buyback Yield / Dilution
-22.64%-22.64%-30.31%--
Total Shareholder Return
-22.64%-22.64%-30.31%0.00%0.00%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).